Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: WHO Regional Office for the Western Pacific
Street 1: PO Box 2932
Street 2:
City: Manila
Province: Metro Manila
Post Code: 1000
Country: Philippines
Phone: 635289704
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr
First Name: Nobu
Last Name: Nishikiori
Title: Team Leader for Tuberculosis and Leprosy

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Tom
Last Name: Hiatt
Title: Technical Officer for Tuberculosis

General Information

Board Constituency: Multilaterals
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Multilateral Organization
Organization Type - Secondary: None
Organization Description:
United Nations technical agency providing support to countries in the Western Pacific region for public health. The Regional Office for the Western Pacific provides support to the following countries with a high-burdent of TB: Cambodia, China, Lao PDR, Mongolia, Papua New Guinea, Philippines and Viet Nam. WPRO also provides support to the Pacific Island Countries.
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Funding, including innovative and optimized approach to funding TB Care
Research and Development
Technical Assistance

Other Organization Information

Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 1 - 5
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
Are you a member of a Stop TB national partnership: Viet Nam
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
The Regional Office for the Western Pacific provides support to the following countries with a high-burdent of TB: Cambodia, China, Lao PDR, Mongolia, Papua New Guinea, Philippines and Viet Nam. WPRO also provides support to the Pacific Island Countries.

Geographical Reach

Which country is your headquarters located in: Philippines
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Brunei Darussalam
Cook Islands
Democratic People's Republic of Korea
Lao People's Democratic Republic
Marshall Islands
Micronesia (Federated States of)
Papua New Guinea
Solomon Islands
Viet Nam


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
The new Regional Strategy to Stop Tuberculosis in the Western Pacific (2011-2015) was developed in consultation with and endorsed by Member States in order to provide guidance to National TB Programmes. The new Strategy builds upon the previous two regional strategic plans and introduces new, evidence-based interventions and technologies in response to the new and emerging challenges. The Strategy provides a reference for action to be taken, focusing on five core objectives: (1) Promoting universal and equitable access to quality TB diagnosis and treatment for all people; (2) Strengthening TB laboratory capacity; (3) Scaling up the programmatic management of drug-resistant TB; (4) Expanding TB/HIV collaborative activities; and (5) Strengthening TB programme management capacity.

Drug-Resistant TB:
WHO has implemented a wide variety of activities to support countries to start and expand the programmatic management of drug-resistant tuberculosis (PMDT) with access to quality MDR-TB drugs through the global Green Light Committee (GLC) mechanism. WHO coordinated and participated in several (GLC) country reviews, facilitated MDR-TB training in Cambodia, organized a Regional workshop on MDR-TB specific recording and reporting, assisted Papua New Guinea in preparing a GLC application, and Lao PDR received GLC approval for the first time. In addition, WHO contributed to international normative guidance and policy-development, through participation in key global committees, thus ensuring Western Pacific region-specific input into global WHO guidelines and donor initiatives. More recently, WHO finalised a novel type of inventory in Laos, Cambodia, Mongolia and Viet Nam, to assist countries in aligning MDR-TB diagnostic and treatment capacities and planning PMDT-scale-up. This is crucial to ensure access to adequate treatment for all identified MDR-TB patients. Based on these findings, WHO will tailor country-specific technical assistance to help national TB programmes develop scale-up plans, pilot MDR-TB interventions and address related human resources needs. As such, WHO combines bottom-up country support with top-down normative guidance and regional policy-development. WPRO has also been selected as one of the pilot regions for the Regional Green Light Committee, which aims to support countries to scale-up MDR-TB management while preventing XDR-TB.

To scale up the response, WHO published A Revised Framework to Address TB-HIV Co-infection in the Western Pacific Region (2008), which emphasizes early diagnosis and recommends that HIV tests and TB screening be provided at TB and HIV clinics, respectively. Since then, progress has been observed in some countries such as Cambodia, Viet Nam and Lao PDR. Especially in Cambodia, HIV testing coverage among TB patients increased from 13% in 2006 to 70% in 2009. In addition, Cambodia took the lead in implementing the “Three I’s” (i.e. Infection control in health facilities, Intensified TB case finding and Isoniazid preventive therapy among people living with HIV). Infection control inventory missions conducted by WHO in 2010 will also support these positive developments in TB/HIV activities.

Laboratory Strengthening:
In 2010, WHO endorsed a new revolutionary TB diagnostic test that will make it possible to decentralize the diagnosis of drug-resistant TB, to reduce the turn-around time of MDR-TB diagnosis from months to hours, to increase the sensitivity of TB diagnosis compared to conventional methods and to share equipment and technicians with other disease programmes. In order to accommodate these new tools, however, countries will need technical assistance (TA) to develop appropriate diagnostic algorithms. In anticipation of these TA needs, WHO held a consultation meeting with the Supra-National Reference Laboratories (SRLs) in the Philippines (July 2010) to discuss the approach. Two regional laboratory trainings, attended by 7 countries with a high-burden of TB, were then held at the Research Institute of Tuberculosis (RIT) in August 2010 and at the Korean Institute of Tuberculosis (KIT) in February 2011, and were facilitated by the supra-national laboratories and the Global Laboratory Initiative.

New Diagnostics:
See Laboratory Strengthening.

Recognizing the need for innovative, country-specific approaches to TB care, WHO will be providing increased support for operational research (and country capacity-building to conduct research) that assesses barriers to TB control as well as the feasibility and cost-effectiveness of related actions to address these barriers. In December 2010, WHO launched the Operational Research Grant Mechanism, which will annually request research proposals from countries for funding.


Declaration of interests:
No conflicts of interest were delacred.

Application date:  
Last updated: February 28, 2014